The objective was to evaluate the automatic ELISA Triturus analyser in order to assess its practicability and imprecision. The analyser was evaluated according to the guidelines of the Spanish Society of Clinical Chemistry. The evaluation was performed in two steps: evaluation of the imprecision and the inaccuracy of a semiquantitative and qualitative technique, and study of the practicability. The within-run imprecision rate ranged from 8.9 (VC) to 10.2% (VC) for the semiquantitative test, and from 11 (VC) to 17.2% (VC) for the qualitative one. The between-run imprecision rate ranged from 6 (VC) to 9.7% (VC) for the semiquantitative test, and from 8.8 (VC) to 18%(VC) for the qualitative technique. No sample-related carryover was detected in negative samples. The relative inaccuracy was correct for both techniques. Non-specific binding caused by waste products from the analysed circuits was not detected. The Triturus analyser is a reliable open analytical system with a considerable working capability, rendering this apparatus adequate for conventional laboratories with a medium-to-high work charge.
Introduction
The Triturus Analyser (Diagnostics Grifols, S.A., Barcelona, Spain) is an immunoassay system. The evaluation reported here was performed according to the guidelines of the Spanish Society of Clinical Biochemistry and Molecular Pathology (SEQC) [1] [2] [3] [4] [5] . It included the study of within-and between-run imprecision, samplerelated carryover, method comparison with patients' specimens, detection limit, and non-specific binding. The analyser's practicability was also evaluated.
Experimental

Instrumentation description
The Triturus Analyser is an open, fully automated, multi-test and -batch immunoassay system. The instrument can perform all steps of a microplate assay including: sample dilution, reagent addition, washings, absorbance reading and results calculation. Programming at every step is also possible.
Several tests can be performed simultaneously on a given sample and the system presents the capability of independently scheduling several consecutive groups of tests. The system can be interfaced with the user's in-house computer for data management and reporting.
Statistical analysis
Data were analysed using the program SPSS 8.0 for Windows.
Reagents
The reagents used in this evaluation were as follows:
. Toxoplasma IgG test set (SeraQuest TM , North Miami, FL 33181, USA). It is an enzyme-linked immunosorbent assay (ELISA) for the semiquantitative detection of human immunoglobulin (Ig) G antibodies to Toxoplasma gondii. The test includes one positive and negative control and two calibrators. The index value or International Units (IU) ml -1 of each sample was calculated by extrapolation in a calibration curve. The calibration curve is performed using two calibrators included by the manufacturer in the kit and using one blank. The interpretation of the results was the following: < 27 IU ml -1 as negative, between 27 and 33 IU ml -1 as equivocal, and > 33 as positive. . Captia TM Epstein-Barr viral Capsid Antigen (EBV VCA P-18) IgG (Trinity Biotech, Jamestown, NY, USA). This test is an ELISA for the qualitative determination of IgG antibodies in human serum to VCA antigen. The technique includes a negative control, two positive controls (high and low control) and three cut-off calibrators used to calculate the test sample index: Test sample index ¼ test sample absorbance/(mean absorbance cut-off calibrator Â correction factor). The correction factor was determined by the manufacturer for each lot in order to account for day-to-day fluctuations in assay activity due to room temperature and timing. The interpretation of the results was as follows: < 0:90 IU ml -1 as negative, between 0.90 and 1.09 IU ml -1 as equivocal, and > 1:09 as positive.
Controls and samples
Human sera containing 0.1% sodium azida were used as controls to validate the performance of the test at three distinct levels. They were supplied by Quest International, Inc. (North Miami, FL 33181, USA). To assess the method comparison, clinical serum specimens were tested.
Evaluation protocol
Imprecision. To evaluate the within-run imprecision, three different samples of control sera were tested. Fifteen replicates of each control sera were tested in three different runs performed on consecutive days, while the between-run imprecision was studied by using three different samples of control sera distributed in 20 different runs performed on consecutive days.
Inaccuracy
Sample-related carryover. The carryover caused by the sample was studied following an alternative permutation order between five control samples with different concentration. Two high concentration specimens (A) followed by three low concentration specimens (B) were processed 10 times (A1 A2 B1 B2 B3).
Method comparison. To assess the method comparison, 107 and 95 serum specimens were tested by EBV IgG ELISA (Gull Laboratories, Inc., Salt Lake City, UT, USA) and VIDAS TOXO IgG (BioMe´rieux S.A., Marcy-l'Etoile, France), respectively, as reference methods. The samples ranged within the analytical interval of both tests. The statistical evaluation was undertaken by a non-parametric method according to Passing and Bablock [6, 7] .
The VIDAS Toxo IgG is an automated assay for the VIDAS system that enables anti-Toxoplasma IgG in human serum to be quantitatively measured. The assay principle combines the enzyme immunoassay method with a final fluorescent detection. The test includes one positive control, one negative control and one calibrator. The results are analysed automatically and the antiToxoplasma IgG sample concentration is calculated by the VIDAS system. The results are expressed in IU ml -1 in relation to a calibration curve stored in the VIDAS system memory and are interpreted following the manufacturer's instructions.
The EBV IgG ELISA test is intended for the quantitative and qualitative detection of IgG antibody to the sp 125 viral capsid antigen of Epstein-Barr virus in human serum by the ELISA method. The test includes negative and positive controls, three calibrators and a reference serum. The test was performed using the manual procedure. Results were interpreted following the manufacturer's recommendations. Non-specific binding. To correct the non-specificity of the antibodies used in the techniques, distilled water was used as samples instead of the specimens. Tables 1 and 2 show the results of the within-and between-run imprecision studies obtained from the Toxoplasma and Epstein-Barr tests, respectively. Results from both tests were acceptable for this kind of techniques. The within-run imprecision rate ranged from 8.9 (VC) to 10.2% (VC) for the semiquantitative test, and from 11 (VC) to 17.2% (VC) for the qualitative assay. The between-run imprecision rate ranged from 6 (VC) to 9.7% (VC) for the semiquantitative test, and from 8.8 (VC) to 18% (VC) for the qualitative method.
Results and discussion
Imprecision
Inaccuracy
Sample-related carryover. No contamination effect was detected in negative samples caused by carryover from positive samples in either of the techniques. The means of B1 and B3 were calculated and compared using the Wilcoxon test [2] . The resulting standard variations were not significant (p > 0:05).
Method comparison. The quantitative method (Toxoplasma IgG test) presented a good correlation with the reference method to a level of 150 IU ml -1 (figure 1). From this point, which corresponds to absorbance units near 2.5, the optical reader of the analyser looses linearity; results higher than this value were non-comparable. Non-specific binding.
Non-specific bindings caused by waste products from the analysed circuits were not detected.
Practicability
Environmental factors. The Triturus Analyser is large and requires quite a large room for installation. It produces noise at a low level and operates at room temperature. An uninterruptible power supply is needed to prevent the analyser from stopping when a fluctuation of alternating current occurs.
Operators' training. Technique programming and unexpected problem resolution requires a good training period and experience. The instrument is easily and quickly understood.
User's information systems:
. Easy to use access screen.
. Screen shows which step the analyser is performing.
. Clear error messages appear on the screen.
Starting delay of the system. The staff begins the daily startup procedure, which takes about 5 min.
It is recommended that a water system washing is performed before starting and at the end of each working day, although the Triturus does an automatic priming before of each series.
Calibration mode. This depends on the ELISA technique, since each assay includes its own calibrators.
Specimens' loading. A 24-h availability is needed to process urgent samples intercalated in a previously programmed specimen series. Eight different techniques can be performed on one sample, provided all the protocols are compatible. The specimen has to be processed in tubes with a maximum diameter of 12-13 mm and 75 mm height. Primary tubes can be used if presenting these characteristics. It can use a barcode for direct sample identification.
Processing speed. It depends on the EIA test. In our study, a maximum of 92 specimens could be processed in 2-3 h.
Methods. This analyser provides only one measure system: spectrophotometry at 405, 450, 492, 550, 600 and 620 nm wavelengths. The measure methods available are the following: cut-off, end-point, curve interpolation (point by point, lineal regression, polynomic regression, spline, 4PL, lin-log and log-log.)
Information processing. Simple data input. Possible direct communication with the laboratory central computer. According to the practicability and reliable results, the Triturus Analyser is adequate for conventional laboratories with medium-to-high work charge. The analyser has the capability to apply multiparametric series provided compatible protocols are used.
